Home > PJ (current issue) > Broad Spectrum | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7436 p104
27 January 2007

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Comment

A solid foundation in science and practice is a must for the NHS's future

By Andrew Husband

Andrew Husband is senior lecturer at the University of Sunderland

The concept of the educational requirements required for a modern pharmacist is once again at the forefront of our thoughts as a profession. The recent valedictory address from Sandy Florence, former dean of the University of London School of Pharmacy (PJ, 28 October 2006, p516), suggested that the constant erosion of science from our undergraduate courses is a dangerous thing and that the replacement of science with practice-based topics may well have an adverse effect on future pharmacists' abilities and the reputation of our pharmacy schools.

This is a concern as the profession considers what we should be teaching undergraduate students to equip them with the necessary knowledge and skills in order that they can effectively contribute to patient care.

The modern pharmacy undergraduate student will often question why particular parts of the syllabus exist and suggest that time would be better spent teaching them things which they “will actually use when I qualify”. In my experience this attitude is widespread and raises the question of exactly what does a student who aspires to become a registered pharmacist think he or she needs to know? More to the point, as undergraduates do they actually know what they will need to know when they are faced will the myriad of questions which may present to any pharmacist during the working day. The answer to this, as Professor Florence opines, possibly resides with the fact that most students and indeed the public formulate their idea of what a pharmacist does based on the model of community pharmacy that they see on the high street. However pharmacy education is not a training programme for community pharmacy.

There is no doubt that most pharmacists will graduate and eventually practise in the community but this is not exclusively the case. Registration as a pharmacist allows for practice in an ever growing number of areas, including the hospital sector, primary care, industry or even academia. The strength of the current MPharm degree and its predecessors is that the qualification lends itself to this diversity and the ability for graduates to call on a wide educational base.

My own experience as a clinical pharmacist in hospital practice demonstrated the fact that a pharmacist can often be the only member of the team able to offer a complete piece of information on matters relating to formulation, chemistry, pharmacokinetics etc. This, along with our extensive understanding of pharmacology, was often the knowledge that was most commonly called upon during ward rounds.

In my mind, more central to this argument is why the distinction between what is science and what is practice has been created. Indeed some academics would argue that practice without science is just what Professed Florence suggests it is — a soft subject with little definition and possibly little outcome.

As a subject, pharmacy practice has certainly become a much greater part of the MPharm syllabus and it is incumbent upon us to ensure that the subject has rigour and clearly defines its purpose. The purpose of pharmacy practice teaching or, possibly more appropriately, clinical pharmacy is certainly to introduce students to the work of a pharmacist. But more importantly it should be used to put the “science” base of the course into the context of patient care and therapeutic decision making. The complexity of modern day medicine is such that a thorough understanding of the reasons why particular therapeutic manoeuvres are made is vital for a profession promoting itself as the experts in medicines. Along with this detailed knowledge of drug delivery systems, how they work and how they may be affected by patient factors, disease factors or concomitant medication is essential, and in the health service context is unique to the pharmacist.

How we do this within the time and resources allocated is the challenge. The use of case-based material, possibly in the clinical environment, to teach students is important and does help to clarify the various roles of pharmacists working in different sectors. This is often reinforced by using clinical guidelines as a description for how to treat a disease in line with current best practice.

While this is of relevance and is clearly important, it is not a substitute for a thorough understanding of how drugs are administered, how they interact with their target site and how they are eliminated. Guidelines may come and go depending on governmental changes but a solid foundation of education in the pharmaceutical sciences, including pharmacy practice, is applicable in any vision of the future NHS. We must add a research ethos so that our graduates leave us with the intention of ensuring that our future role as a profession is supported and clarified by a robust and technically appropriate research base. It is this knowledge, put into context by thorough, up-to-date practice teaching, which may be used to oppose opinions aligning our advisory skills in relation to medicines with that of employees of a garage forecourt.

It is clear that pharmacy education is changing and has changed over a number of years resulting in certain areas of the syllabus being consigned to history. Others, such as folding powders and extemporaneous preparation of suppositories, have a dubious place in the modern education of a pharmacist in the eyes of some commentators, possibly correctly so.

As we reformulate the education of pharmacy undergraduates we should take care not to lose what makes us unique. That said, to label newer subjects as undefinable or without academic rigour, based on the fact that they are not perceived to be part of the traditional pharmaceutical sciences, is unwise. Pharmacy practice, including clinical pharmacy, should be the glue that holds the various strands of science together and places them into the context of the patient ensuring that our students are aware of the complete reasons for why we treat disease the way we do.

It is a popular opinion to oppose extended pharmacist involvement in prescribing, for example, on the basis that we lack training in diagnostic skills. Although this is correct maybe we should, as Professor Florence suggests, blast our trombones and highlight the expertise in therapeutics and all that it entails which could contribute immeasurably to the care of patients and the effectiveness of the NHS.

Back to Top


©The Pharmaceutical Journal